Compare HLN & FMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLN | FMX |
|---|---|---|
| Founded | 2022 | 1890 |
| Country | United Kingdom | Mexico |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Beverages (Production/Distribution) |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 38.1B |
| IPO Year | N/A | 1998 |
| Metric | HLN | FMX |
|---|---|---|
| Price | $10.09 | $107.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | N/A | ★ $108.83 |
| AVG Volume (30 Days) | ★ 8.0M | 342.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.81% | ★ 6.50% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.04 | $10.25 |
| Revenue Next Year | $4.58 | $8.35 |
| P/E Ratio | $49.05 | ★ $40.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.71 | $83.08 |
| 52 Week High | $11.42 | $116.09 |
| Indicator | HLN | FMX |
|---|---|---|
| Relative Strength Index (RSI) | 37.81 | 43.91 |
| Support Level | $9.48 | $104.99 |
| Resistance Level | $10.31 | $115.35 |
| Average True Range (ATR) | 0.16 | 2.79 |
| MACD | -0.12 | -0.77 |
| Stochastic Oscillator | 9.68 | 15.15 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.